UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overcoming Barriers to Latino Participation in Alzheimer's Disease Research

International journal of aging & human development, 2024-08, p.914150241268259

2024

Volltextzugriff (PDF)

T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12265-n/a

2022

Volltextzugriff (PDF)

Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration

Journal of Alzheimer's disease, 2021-01, Vol.84 (4), p.1431-1438

2021

Volltextzugriff (PDF)

Case 279: Central-Variant Posterior Reversible Encephalopathy Syndrome

Radiology, 2020-07, Vol.296 (1), p.239-243

2020

Volltextzugriff (PDF)

Case 279

Radiology, 2020-03, Vol.294 (3), p.714-715

2020

Volltextzugriff (PDF)

Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells

Journal of Alzheimer's disease, 2020-01, Vol.75 (1), p.119-138

2020

Volltextzugriff (PDF)

Mapping a Reliable Stroke Onset Time Course Using Signal Intensity on DWI Scans

Journal of neuroimaging, 2019-07, Vol.29 (4), p.476-480

2019

Volltextzugriff (PDF)

Abstract 86: Nationwide Differences in Care and Outcomes of Acute Ischemic Stroke

Stroke (1970), 2019-02, Vol.50 (Suppl_1)

2019

Volltextzugriff (PDF)

Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication

Journal of Alzheimer's disease, 2019-01, Vol.67 (2), p.707-713

2019

Volltextzugriff (PDF)

Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-07, Vol.320 (2), p.156

2018

Volltextzugriff (PDF)

P3‐032: SCREENING‐TO‐BASELINE COGNITIVE VARIABILITY DOES NOT PREDICT RATE OF DECLINE IN A CLINICAL TRIAL OF MILD‐TO‐MODERATE AD

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_20), p.P1076-P1077

2018

Volltextzugriff (PDF)

SCREENING-TO-BASELINE COGNITIVE VARIABILITY DOES NOT PREDICT RATE OF DECLINE IN A CLINICAL TRIAL OF MILD-TO-MODERATE AD

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P1076-P1077

2018

Volltextzugriff (PDF)

The Sustained DeyeCOM Sign as a Predictor of Large Vessel Occlusions and Stroke Mimics

Journal of stroke and cerebrovascular diseases, 2018-06, Vol.27 (6), p.1466-1470

2018

Volltextzugriff (PDF)

Time Intervals of Symptomatic Intracereberal Hemorrhage (sICH) after Tissue Plasminogen Activator (rt-PA) Treatment (P4.241)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Utilization, Outcomes and Safety of IV tPA for Acute Ischemic Stroke during pregnancy (P4.034)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Anticoagulant Use Is Not Associated With Higher Post tPA Hemorrhagic Conversion (P4.240)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Memantine and Cholinesterase Inhibitor Use in Alzheimer Disease Trials: Potential for Confounding by Indication (P6.178)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)